But on the other hand.... this company would make an attractive takeover.
Good executive and sales team
Radiopharma sector
Some approvals
Some sales
Path to reimbursement in Germany
Increasing public funded research leading to more sales
Application for HDE with FDA
And cheap. Really cheap.
Ann: Fully-Funded Trial Approved In Germany, page-17
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $23.78M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $34.37K | 5.002M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 4929003 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 23400459 | 26 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |